| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 2112737-73-0 | DSPE-PEG5-azide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 292843-75-5 | Biotin-PEG2-C2-iodoacetamide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 2112737-93-4 | DSPE-PEG5-propargyl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 344768-30-5 | UBP141 |
≥98% | | 询价 |
| 5 | 1214319-92-2 | Azido-PEG8-acid |
≥98% | | 询价 |
| 6 | 1428307-52-1 | MRT-92 HCl salt |
≥98% | | 询价 |
| 7 | 94149-41-4 | Midesteine |
≥98% | | 询价 |
| 8 | 127294-70-6 | Balofloxacin |
≥98% | | 询价 |
| 9 | 876310-60-0 | RF9 |
≥98% | | 询价 |
| 10 | 1310827-27-0 | Azido-PEG3-SS-PEG3-azide |
≥98% | | 询价 |
| 11 | 129075-56-5 | PD-128763 |
≥98% | | 询价 |
| 12 | 142437-67-0 | Amthamine |
≥98% | | 询价 |
| 13 | 3688-53-7 | Furylfuramide |
≥98% | | 询价 |
| 14 | 1351373-47-1 | Bis-propargyl-PEG10 |
≥98% | | 询价 |
| 15 | 17606-31-4 | Bensultap |
≥98% | | 询价 |
| 16 | 1000005-71-9 | ATL-801 |
≥98% | | 询价 |
| 17 | 1449765-82-5 | SLP7111228 |
≥98% | | 询价 |
| 18 | 1192760-33-0 | Aganepag ethanediol |
≥98% | | 询价 |
| 19 | 333-43-7 | AI 3-25713 |
≥98% | | 询价 |
| 20 | 1619884-65-9 | PSB-1434 |
≥98% | | 询价 |
| 21 | 903580-39-2 | PRX-07034 |
≥98% | | 询价 |
| 22 | 106134-33-2 | Ro 22-9194 |
≥98% | | 询价 |
| 23 | 51543-40-9 | Tarenflurbil |
≥98% | | 询价 |
| 24 | 1398046-21-3 | Proxalutamide |
≥98% | | 询价 |
| 25 | 470-37-1 | Cinobufagin |
≥98% | | 询价 |
| 26 | 74050-97-8 | Haloperidol decanoate |
≥98% | | 询价 |
| 27 | 111113-75-8 | 5,6,7,8-Tetrahydro-8-deazahomofolic acid |
≥98% | | 询价 |
| 28 | 2135793-73-4 | m-PEG12-acid |
≥98% | | 询价 |
| 29 | 1254044-38-6 | Mito-apocynin(C11) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 41307-63-5 | Resorcinolnaphthalein |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 2363130-04-3 | DBCO-PEG5-DBCO |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 2411681-88-2 | Thalidomide-O-PEG4-NHS ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | | TCO-PEG12-TFP ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 2173125-29-4 | S-acetyl-PEG3-phosphonic acid ethyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | | N-Boc-PEG24-alcohol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 2055041-21-7 | Acid-PEG4-S-PEG4-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 2173095-09-3 | m-PEG3-S-PEG2-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | | Thalidomide-O-amido-PEG4-propargyl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 2093153-08-1 | N-Boc-N-bis(PEG4-NHS ester) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | | S-acetyl-PEG16-alcohol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | | Bis-PEG25-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 42749-27-9 | Bis-Tos-PEG6 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | | Tos-PEG13-Boc |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 2093152-85-1 | N-Azido-PEG4-N-Boc-N-PEG3-Boc |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 2112738-14-2 | DSPE-PEG4-DBCO |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 2022986-70-3 | KRAS inhibitor-8 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 2022986-61-2 | KRAS inhibitor-6 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 1254044-41-1 | Mito-apocynin(C2) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 1699861-37-4 | BMS-901715 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 3542-63-0 | CDK9-IN-10 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 387-79-1 | 17a-Hydroxypregnenolone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 138516-31-1 | Bisindolylmaleimide VIII acetate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 5937-72-4 | Androstenediol 17-acetate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 841-73-6 | Bucolome |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 93047-40-6 | Naminterol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 2182601-79-0 | Bis(m-PEG4)-N-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 2055041-59-1 | NH-bis(PEG4-acid) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 165806-53-1 | SB220025 |
≥98% | | 询价 |
| 59 | 160391-70-8 | Entacapone Acid |
≥98% | | 询价 |
| 60 | 693-23-2 | Dodecanedioic acid |
≥98% | | 询价 |
m.cnreagent.com